| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5158435 | European Journal of Medicinal Chemistry | 2017 | 12 Pages |
Abstract
CXCR4 and its natural ligand SDF-1α are involved in a number of pathological processes including cancer spread and progression. Herein we provide a comprehensive summary of small molecules recently claimed as CXCR4 antagonists potentially useful for cancer treatment.270
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Fedora Grande, Gilda Giancotti, Giuseppina Ioele, Maria A. Occhiuzzi, Antonio Garofalo,